Treatment of abnormal cervical cells related to HPV is a large market. There are 50m pap tests performed each year in the US alone, with approximately 5% returning an abnormal test result. Most of these cases are LSIL, with the number of HSIL cases around 500,000 in the US according to the American College of Pathology, with a similar amount in Europe, making the addressable market around one million in those areas. According to estimates provided by the company, in China, 1â2% of women are diagnosed with HSIL every year, indicating a potential market size of seven to 14 million.
Denne analysen fra 2019 er interessant lesning, antakeligvis mest for oss som er nye i caset.